Guardant Health
GH
#1177
Rank
$19.78 B
Marketcap
$149.22
Share price
4.39%
Change (1 day)
193.39%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of March 2026 : -$0.19 Billion USD

According to Guardant Health 's latest financial reports the company has -$0.19 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-$99.31 Million-28.89%
2024-12-31$-$0.14 Billion-188%
2023-12-31$$0.15 B163.68%
2022-12-31$$60.18 M-90.67%
2021-12-31$$0.64 B-52.42%
2020-12-31$$1.35 B59.86%
2019-12-31$$0.84 B61.54%
2018-12-31$$0.52 B70.1%
2017-12-31$$0.30 B287.23%
2016-12-31$$79.69 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Neogen
NEOG
$2.10 B-1,261.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
$1.77 B-1,079.73%๐Ÿ‡บ๐Ÿ‡ธ USA